Log in to save to my catalogue

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Ca...

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1760931681

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma

About this item

Full title

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma

Publisher

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

Journal title

The American journal of gastroenterology, 2016-01, Vol.111 (1), p.70-77

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

More information

Scope and Contents

Contents

The Barcelona Clinic Liver Cancer (BCLC) intermediate stage (BCLC B) includes a heterogeneous population of patients with hepatocellular carcinoma (HCC). Recently, in order to facilitate treatment decisions, a panel of experts proposed to subclassify BCLC B patients. In this study, we aimed to assess the prognostic capability of the BCLC B stage re...

Alternative Titles

Full title

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1760931681

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1760931681

Other Identifiers

ISSN

0002-9270

E-ISSN

1572-0241

DOI

10.1038/ajg.2015.389

How to access this item